GLO HEALTHCARE Trademark

Trademark Overview


On Tuesday, March 14, 2023, a trademark application was filed for GLO HEALTHCARE with the United States Patent and Trademark Office. The USPTO has given the GLO HEALTHCARE trademark a serial number of 97837490. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 11, 2025. This trademark is owned by GLO New TopCo SCA. The GLO HEALTHCARE trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for human use in diagnosis and therapy of diseases in the fields of oncology, renal disease, cardiology, lung disease, bone disease and neuroscience; Radiopharmaceutical preparations for use in diagnostic imaging, for use in therapeutic treatments, namely the destruction of diseased tissue, and for use in the treatments of non-cancerous conditions, namely the treatment of blood disorders, and for reducing the function of overactive thyroid glands; Pharmaceutical kits for making radiopharmaceutical preparations for nuclear medical use, namely kits comprising diagnostic radioisotopes and therapeutic radioisotopes, and also containing chelating chemical agents, reducing chemical agents, buffers, ligands and targeting molecules, chemical solvents, chemical stabilizers and preservatives, isotope exchange and radiolabeling reagents, radionuclide generators, sterilizing agents, and printed and downloadable instruction manuals for synthesis, all sold as a unit

Medical generators specially adapted for medical purposes, namely for use in the production and transportation of nuclear medicine and component parts therefor; Radioaerosol generators, namely, nebulizers for medical use for administering radioactive medicine and imaging solutions in gaseous form for medical imaging procedures and component parts therefor; Elution shields for medical use, namely, nuclear medicine radiation apparatus for collection of sodium-pertechnetate from Mo99/Tc99m generators and radiation shielding

Pharmaceutical research and development services; providing medical research and scientific research information in the field of pharmaceuticals
glo healthcare

General Information


Serial Number97837490
Word MarkGLO HEALTHCARE
Filing DateTuesday, March 14, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 11, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use in diagnosis and therapy of diseases in the fields of oncology, renal disease, cardiology, lung disease, bone disease and neuroscience; Radiopharmaceutical preparations for use in diagnostic imaging, for use in therapeutic treatments, namely the destruction of diseased tissue, and for use in the treatments of non-cancerous conditions, namely the treatment of blood disorders, and for reducing the function of overactive thyroid glands; Pharmaceutical kits for making radiopharmaceutical preparations for nuclear medical use, namely kits comprising diagnostic radioisotopes and therapeutic radioisotopes, and also containing chelating chemical agents, reducing chemical agents, buffers, ligands and targeting molecules, chemical solvents, chemical stabilizers and preservatives, isotope exchange and radiolabeling reagents, radionuclide generators, sterilizing agents, and printed and downloadable instruction manuals for synthesis, all sold as a unit
NOT AVAILABLE"HEALTHCARE"
Goods and ServicesMedical generators specially adapted for medical purposes, namely for use in the production and transportation of nuclear medicine and component parts therefor; Radioaerosol generators, namely, nebulizers for medical use for administering radioactive medicine and imaging solutions in gaseous form for medical imaging procedures and component parts therefor; Elution shields for medical use, namely, nuclear medicine radiation apparatus for collection of sodium-pertechnetate from Mo99/Tc99m generators and radiation shielding
Goods and ServicesPharmaceutical research and development services; providing medical research and scientific research information in the field of pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 3, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, April 3, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 3, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGLO New TopCo SCA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLuxembourg 1118
LU

Party NameGLO New TopCo SCA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLuxembourg 1118
LU

Trademark Events


Event DateEvent Description
Monday, April 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 17, 2023NEW APPLICATION ENTERED
Tuesday, December 12, 2023ASSIGNED TO EXAMINER
Wednesday, December 27, 2023NON-FINAL ACTION WRITTEN
Wednesday, December 27, 2023NON-FINAL ACTION E-MAILED
Wednesday, December 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 26, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, March 26, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, April 3, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 17, 2024FINAL REFUSAL E-MAILED
Thursday, October 17, 2024FINAL REFUSAL WRITTEN
Tuesday, September 3, 2024ASSIGNED TO LIE
Thursday, October 17, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, December 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 16, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, January 14, 2025EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, January 14, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, January 14, 2025EX PARTE APPEAL-INSTITUTED
Tuesday, February 4, 2025EXAMINER'S AMENDMENT ENTERED
Tuesday, February 4, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 4, 2025EXAMINERS AMENDMENT E-MAILED
Tuesday, February 4, 2025EXAMINERS AMENDMENT -WRITTEN
Friday, February 14, 2025LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 14, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 14, 2025EXPARTE APPEAL TERMINATED
Wednesday, March 5, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 11, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 11, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED